Skip to main content
Fig. 4 | Cancer Cell International

Fig. 4

From: Potential use of EGFR-targeted molecular therapies for tumor suppressor CYLD-negative and poor prognosis oral squamous cell carcinoma with chemoresistance

Fig. 4

Effect of EGFR targeted inhibitors on cell viability of CYLD-knockdown OSCC cells. Cells were treated with erlotinib (A), afatinib (B), osimertinib (C) and cetuximab (D), and the cell survival rates were assessed 72 h after treatment. Values Scale bar shows 200 µm. Values are means ± S.D. of triplicate samples. **p < 0.01 vs siN group in Tukey–Kramer method

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us